安德利(605198.SH):與帝斯曼果膠簽署《果渣供應協議》
格隆匯2月12日丨安德利(605198.SH)公佈,公司與帝斯曼果膠簽署《果渣供應協議》,協議有效期自簽署且經公司第八屆董事會第二十七次會議審議通過之日起三年,協議期內本公司(含附屬公司)供應量總計爲39,000噸,每個合同年度果渣供應量至少爲13,000噸,除非在協議期內本公司全部果渣產量(合併計算)的95%低於39,000噸,且本公司已經將合同年度內全部果渣產量的95%供應給了帝斯曼果膠。協議期內每自然年度交易金額上限爲人民幣4,200.00萬元,本公司2024年審計報告出具後調整該年度的交易金額上限,調整後的金額不超過本公司2024年度經審計銷售收入的5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.